This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

8 Stocks Hitting New Highs Today

BioMarin Pharmaceutical

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

BioMarin Pharmaceutical (BMRN) develops and commercializes pharmaceuticals for serious diseases and medical conditions. This stock is trading up 1.1% to $36.00 in recent trading after hitting a 52-week high of $36.13 earlier in the day.

Today's Range: $35.47-$36.13

52-Week Range: $23.09-$35.94

Volume: 225,000

Three-Month Average Volume: 803,464

BioMarin Pharmaceutical has a market cap of $4.11 billion and an enterprise value of $4.19 billion. This stock trades at a price-to-sales of 9.34 and a price-to-book of 5.25. Its estimated growth rate for this year is -120.2%, and for next year it's pegged at 8.6%. The current short interest as a percentage of the float for BioMarin Pharmaceutical is notable at 6.8%.

From a technical standpoint, BMRN has started to trigger a major breakout trade today now that the stock is taking out some past overhead resistance at $35.47 to $35.56. The only thing lacking on this breakout is heavy volume, since only 225,000 shares have traded versus its average volume of 803,463.

That said, price always trumps volume, so if BMRN can sustain a move and close over $35.56, then it has a shot at trading back toward its all-time high at $40. Traders should continue to monitor the volume in the coming days to see if it firms up, and continue to look for long-biased trades as long as BMRN continues its trend above $35.47 to $35.56.

As of the most recently reported quarter, BioMarin is one of the top holdings in Columbia Wanger Asset Management's portfolio.

3 of 9

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs